European Biotechnology Network (EBN) is delighted to announce the launch of the agenda and registration for the 1st European Biotechnology Network Convention, taking place on 23 – 24 June 2016 in Brussels. With a strong focus on all aspects of scientific and business collaboration, the Convention will bring together members from European SMEs, large companies, research organisations, public and private funders and policy makers that impact the biotechnology sector.
Who should attend? All professional actors in biotechnology who are interested in
Public funding: opportunities and experiences
European Commission’s strategy on biotechnology
Private financing – where the money is
Collaboration – exclusive expert advice in key areas
Open innovation in pharma boosting joint R&D innovations
Communication and dissemination: do’s and dont’s
Recent scientific breakthroughs and their impact on the industry
Keynote speakers are:
Waldemar Kütt, European Commission, DG Research & Innovation: European Commission’s strategy on biotechnology
Pierre Meulien, Innovative Medicines Initiative (IMI), Executive Director: Delivering on the promise of the genome
Marcel Wubbolts, DSM, Chief Technology Officer: Bioeconomy – disruptive technologies for the industry
Find more information about the convention and its programme at http://convention.european-biotechnology.net Source: European Biotechnology Network
